Latest Documents


  • 11-January-2017

    English

    Pharmaceuticals

    Pharmaceuticals have undoubtedly contributed to improvements in life expectancy and quality of life of many patients, but recent trends on increased spending and soaring launch prices of new medicines raise a number of concerns.

    Related Documents
  • 10-January-2017

    English

    Reviews of National Health Care Quality

    OECD Health Care Quality Reviews seek to examine what works and what does not work in different countries – both to benchmark the efforts of countries and to provide advice on reforms to improve their health system.

  • 10-January-2017

    English

    Tackling Wasteful Spending on Health

    Following a brief pause after the economic crisis, health expenditure is rising again in most OECD countries. Yet, a considerable part of this health expenditure makes little or no contribution to improving people's health. In some cases, it even results in worse health outcomes. Countries could potentially spend significantly less on health care with no impact on health system performance, or on health outcomes. This report systematically reviews strategies put in place by countries to limit ineffective spending and waste. On the clinical front, preventable errors and low-value care are discussed. The operational waste discussion reviews strategies to obtain lower prices for medical goods and to better target the use of expensive inputs. Finally, the report reviews countries experiences in containing administrative costs and integrity violations in health.

  • 21-December-2016

    English

    Pharmaceutical Pricing Policy project

    The policy study published by the OECD is based on six case studies, an extensive review of the literature, and analysis of relevant data. The report provides context for the analysis of pharmaceutical pricing policies in OECD countries, describes pricing policies employed by the OECD zone and assesses their impact.

  • 21-December-2016

    English

    Value in Pharmaceutical Pricing

    The Working Paper sheds light on the extent to which “value” is considered in pricing and/or coverage decisions in 14 OECD member countries. It describes methods used by countries to assess the therapeutic benefits of new products, as well as approaches for economic evaluation, where relevant, and aims to illustrate how value is assessed and what is its impact on pricing and/or reimbursement decisions.

    Related Documents
  • 16-December-2016

    English

    Health Workforce

    Health workers are crucial for ensuring access to high quality care for the whole population. The OECD advises countries on how to meet future demand for health professionals and how to manage the supply of health workers, by reviewing policies related to education and training, continuous professional development, geographic distribution and immigration.

    Related Documents
  • 9-December-2016

    English

    Antimicrobial Resistance

    Antimicrobial resistance is a growing health and economic threat requiring multipronged responses. The OECD provides a forum for discussion and provide countries with the evidence to implement effective and cost-effective policies to tackle AMR, promote effective use of antimicrobials and incentivise research and development in the antibiotic sector.

  • 8-December-2016

    English

    Primary Care Review of Denmark

    In many ways, primary care in Denmark performs well. Danish primary care is trusted and valued by patients, and is relatively inexpensive. But there are important areas where it needs to be strengthened. Most critically, Danish primary care is relatively opaque in terms of the performance data available at local level. Greater transparency is vital in the next phase of reform and sector strengthening.

    Related Documents
  • 28-November-2016

    English

    Data for Measuring Health Care Quality and Outcomes

    The objective of the HCQI Project is to develop a set of indicators based on comparable data and which can be used to raise questions for further investigation on quality differences across countries.

  • 23-November-2016

    English

    Health at a Glance: Europe 2016 - State of Health in the EU Cycle

    This fourth edition of Health at a Glance: Europe presents key indicators of health and health systems in the 28 EU countries, 5 candidate countries to the EU and 3 EFTA countries. This 2016 edition contains two main new features: two thematic chapters analyse the links between population health and labour market outcomes, and the important challenge of strengthening primary care systems in European countries; and a new chapter on the resilience, efficiency and sustainability of health systems in Europe, in order to align the content of this publication more closely with the 2014 European Commission Communication on effective, accessible and resilient health systems. This publication is the result of a renewed collaboration between the OECD and the European Commission under the broader "State of Health in the EU" initiative, designed to support EU member states in their evidence-based policy making.

     

  • << < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 > >>